DRNA
Dicerna Pharmaceuticals, Inc.
DRNA
DRNA
Delisted
DRNA was delisted on the 27th of December, 2021.
40 hedge funds and large institutions have $146M invested in Dicerna Pharmaceuticals, Inc. in 2014 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 17 increasing their positions, 10 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding in top 10
Funds holding in top 10: →
47% less capital invested
Capital invested by funds: $274M → $146M (-$128M)
Holders
40
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$3.31M | |
| 2 | +$1.71M | |
| 3 | +$982K | |
| 4 |
Alyeska Investment Group
Chicago,
Illinois
|
+$871K |
| 5 |
Morgan Stanley
New York
|
+$518K |
Top Sellers
| 1 | -$12.1M | |
| 2 | -$1.77M | |
| 3 | -$395K | |
| 4 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
-$344K |
| 5 |
Charles Schwab
San Francisco,
California
|
-$238K |